Hypoxia and acidity regulate immune checkpoint molecule and IFN-β expression in non-small cell lung cancer cell lines

References

• National Cancer Institute. Surveillance, epidemiology and end results program; 2021 [cited 2021 June 24]. Available at: https://seer.cancer.gov/statfacts/html/lungb.html.
   Google Scholar
• Pirker R. Adjuvant chemotherapy in patients with completely resected non-small cell lung cancer, transl. Lung Cancer Res. 2014;3:305–310.
   Google Scholar
• Lei Q, Wang D, Sun K, et al. Resistance mechanisms of anti-PD1/PDL1 therapy in solid tumors. Front Cell Dev Biol. 2020;8:672.
   PubMed Web of Science ®Google Scholar
• Greenfield EA, Nguyen KA, Kuchroo VK. CD28/B7 costimulation: a review. Crit Rev Immunol. 1998;18(5):389–418.
   PubMed Web of Science ®Google Scholar
• Oronsky B, Carter C, Reid T, et al. Just eat it: a review of CD47 and SIRP-α antagonism. Semin Oncol. 2020;47(2-3):117–124.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A. Warburg effect, lactate dehydrogenase, and radio/chemotherapy efficacy. Int J Radiat Biol. 2019;95(4):408–426.
   PubMed Web of Science ®Google Scholar
• Damgaci S, Ibrahim-Hashim A, Enriquez-Navas PM, et al. Hypoxia and acidosis: immune suppressors and therapeutic targets. Immunology. 2018;154(3):354–362.
   PubMed Web of Science ®Google Scholar
• Li A, Yi M, Qin S, et al. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy. J Hematol Oncol. 2019;12(1):35.
   PubMedGoogle Scholar
• Giatromanolaki A, Sivridis E, Koukourakis MI. The pathology of tumor stromatogenesis, cancer. Cancer Biol Ther. 2007;6(5):639–645.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A, Harris AL, et al. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res. 2006;66(2):632–637.
   PubMed Web of Science ®Google Scholar
• Schito L, Semenza GL. Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer. 2016;2(12):758–770.
   PubMed Web of Science ®Google Scholar
• Rohani N, Hao L, Alexis MS, et al. Acidification of tumor at stromal boundaries drives transcriptome alterations associated with aggressive phenotypes. Cancer Res. 2019;79(8):1952–1966.
   PubMed Web of Science ®Google Scholar
• Noman NZ, Hasmim M, Messai Y, et al. Hypoxia: a key player in antitumor immune response. A review in the theme: cellular responses to hypoxia. Am J Physiol Cell Physiol. 2015;309(9):C569–C579.
   PubMed Web of Science ®Google Scholar
• Noman NZ, Desantis S, Janji B, et al. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med. 2014;211(5):781–790.
   PubMed Web of Science ®Google Scholar
• Koh YW, Lee SJ, Han JH, et al. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: a study based on immunohistochemistry and RNA sequencing data. Lung Cancer. 2019;129:41–47.
   PubMed Web of Science ®Google Scholar
• Zahnreich S, Gebrekidan S, Multhoff G, et al. Oxygen deprivation modulates EGFR and PD-L1 in squamous cell carcinomas of the head and neck. Front Oncol. 2021;11:623964.
   PubMed Web of Science ®Google Scholar
• Karimi S, Mansouri S, Mamatjan Y, et al. Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression. Sci Rep. 2020;10(1):14115.
   PubMed Web of Science ®Google Scholar
• Mori D, Tsujikawa T, Sugiyama Y, et al. Extracellular acidity in tumor tissue upregulates programmed cell death protein 1 expression on tumor cells via proton-sensing G protein-coupled receptors. Int J Cancer. 2021;149(12):2116–2124.
   PubMed Web of Science ®Google Scholar
• Giatromanolaki A, Koukourakis IM, Balaska K, et al. Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis. Med Oncol. 2019;36(9):76.
   PubMed Web of Science ®Google Scholar
• Lahat N, Rahat MA, Ballan M, et al. Hypoxia reduces CD80 expression on monocytes but enhances their LPS-stimulated TNF-alpha secretion. J Leukoc Biol. 2003;74(2):197–205.
   PubMed Web of Science ®Google Scholar
• Mancino A, Schioppa T, Larghi P, et al. Divergent effects of hypoxia on dendritic cell functions. Blood. 2008;112(9):3723–3734.
   PubMed Web of Science ®Google Scholar
• Martínez D, Vermeulen M, von Euw E, et al. Extracellular acidosis triggers the maturation of human dendritic cells and the production of IL-12. J Immunol. 2007;179(3):1950–1959.
   PubMed Web of Science ®Google Scholar
• Deng L, Liang H, Xu M, et al. STING-Dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity. 2014;41(5):843–852.
   PubMed Web of Science ®Google Scholar
• Miar A, Arnaiz E, Bridges E, et al. Hypoxia induces transcriptional and translational downregulation of the type I IFN pathway in multiple cancer cell types. Cancer Res. 2020;80(23):5245–5256.
   PubMed Web of Science ®Google Scholar
• Köhler T, Reizis B, Johnson RS, et al. Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration. Eur J Immunol. 2012;42(5):1226–1236.
   PubMed Web of Science ®Google Scholar
• Fan C, Wu J, Shen Y, et al. Hypoxia promotes the tolerogenic phenotype of plasmacytoid dendritic cells in head and neck squamous cell carcinoma. Cancer Med. 2022;11(4):922–930.
   PubMed Web of Science ®Google Scholar
• Flück K, Breves G, Fandrey J, et al. Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis. Mucosal Immunol. 2016;9(2):379–390.
   PubMed Web of Science ®Google Scholar
• Wood EG, Macdougall CE, Blythe H, et al. HIF1α activation in dendritic cells under sterile conditions promotes an anti-inflammatory phenotype through accumulation of intracellular lipids. Sci Rep. 2020;10(1):20825.
   PubMed Web of Science ®Google Scholar
• Tong L, Yue P, Yang Y, et al. Motility and mechanical properties of dendritic cells deteriorated by extracellular acidosis. Inflammation. 2021;44(2):737–745.
   PubMed Web of Science ®Google Scholar